The apoptosis-inducing effects of HIV vpr recombinant eukaryotic expression vectors with different mutation sites on transfected hela cells

Current HIV Research

Volumn 7, Issue 5, 2009, Pages 519-525

  Zheng, Yuhuang ^a   Zhou, Huaying ^a   Zhang, Chunying ^a   He, Yan ^a   Li, Hui ^a   Chen, Zi ^a   Liu, Meng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase pathway; Hela cell; Human immunodeficiency virus type 1; Mutation; Vpr gene

Indexed keywords

CASPASE 3; LIPOSOME; VPR PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; NONHUMAN; RECOMBINANT PLASMID; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

APOPTOSIS; CASPASE 3; GENETIC VECTORS; HELA CELLS; HIV-1; HUMANS; MUTATION; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFTWARE; TRANSFECTION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70350724730     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209789346291     Document Type: Article

References (16)

1. Hogan TH, Nonnemacher MR, Krebs FC, et al. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother 2003; 57: 41-48
2. Tristem M, Marshall C, Karpas A, Hill F. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 1992; 11: 3405-3412
3. Zheng YH, Zhou HY, Lai LY, et al. Diversity of the vpr gene of human immunodeficiency virus type 1 in South China. Chin J Inf Dis 2009; 27(1): 35-41.
4. Ding PP, Zheng YH, Gong GZ, et al. The establishment of a cell strain expressing HIV vpr and the study on Vpr induced apoptosis. Chin J Microbiol Immunol 2008; 28(6): 545-550
5. Elder RT, Yu M, Chen M, et al. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe). Virology 2001; 287: 359-370
6. Wecker K, Morellet N, Bouaziz S, et al. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. Eur J Biochem 2002; 269: 3779-3788
7. Gaynor C. Analysis of apoptosis induced by HIV Vpr and examination of the possible role of the HI23A protein. Exp Cell Res 2001; 267(2): 243-257
8. Anderson JL, Planelles V. The role of Vpr in HIV pathogenesis. Curr HIV Res 2005; 3: 43-51.
9. Yedavalli VS, Shin HM, Chiang YP, et al. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol 2005; 79: 13735-13746
10. Wang B, Ge YC, Palasanthiran P, et al. Gene Defects Clustered at the C-Terminus of the vpr Gene of HIV-1 in Long-Term Nonprogressing Mother and Child Pair: In Vivo Evolution of vpr Quasispecies in Blood and Plasma. Virology 1996; 223: 224-232
11. Jian H, Zhao LJ. Pro-apoptotic Activity of HIV-1 Auxiliary Regulatory Protein Vpr Is Subtype-dependent and Potently Enhanced by Nonconservative Changes of the Leucine Residue at Position 64. J Biol Chem 2003; 278: 44326-44330 (Pubitemid 37377179)
12. Lum JJ, Cohen OJ, Nie Z, et al. Vpr R77Q is associated with longterm nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 2003; 111: 1547-1554
13. Fischer A, Lejczak C, Lambert C, et al. Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection? AIDS 2004; 18: 1346-1347
14. DeHart JL, Erik S, Zimmerman A, et al. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virol J 2007; 4: 57-66.
15. Cartas M, Singh SP, Serio D, et al. Intravirion display of a peptide corresponding to the dimer structure of protease attenuates HIV-1 replication. DNA Cell Biol 2001; 20: 797-805. (Pubitemid 34161274)
16. Sabbah EN, Druillennec S, Morellet N, et al. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator. Chem Biol Drug Des 2006; 67: 145-154 (Pubitemid 43881375)